Fumonisin contamination of food: Progress in development of biomarkers to better assess human health risks

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 443, Issue 1-2, 1999, Pages 81-93

  Turner, P C ^a   Nikiema, P ^b   Wild, C P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

Author keywords

Biomarker; Fumonisin; Mycotoxin; Oesophageal cancer; Sphinganine

Indexed keywords

BIOCHEMICAL MARKER; CERAMIDE; FUMONISIN B1; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE ACYLTRANSFERASE;

ANIMAL MODEL; CARCINOGENICITY; ESOPHAGUS CANCER; FOOD CONTAMINATION; HEALTH HAZARD; HORSE; HUMAN; LEUKOENCEPHALOPATHY; LIVER TOXICITY; LUNG EDEMA; MAIZE; METHODOLOGY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; SWINE;

ANIMALIA; EQUIDAE; FUSARIUM; FUSARIUM MONILIFORME; GIBBERELLA FUJIKUROI; SPHINGIODEA; ZEA MAYS;

EID: 0033565752     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(99)00012-5     Document Type: Article

References (97)

1. Gelderblom W.C.A., Jaskiewicz K., Marasas W.F.O., Thiel P.G., Horak R.N., Vlegger R., Kriek N.P. Fumonisins - novel mycotoxins with cancer promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 54:1988;1806-1811.
2. S.C. Bezuidenhout, W.C.A. Gelderblom, C.P. Gorst-Allman, R.M. Horak, W.F.O. Marasas, G. Spiller, R. Vleggaar, Structure elucidation of the fumonisins, mycotoxins from Fusarium moniliforme, J. Chem. Soc. Chem. Commun. (1988) 743-745.
3. 1, a mycotoxin produced by Fusarium moniliforme, in maize. J. Agric. Food Chem. 38:1990;285-290.
4. W.F.O. Marasas, P.E. Nelson, T.A. Toussoun, Toxigenic Fusarium Species: Identity and Mycotoxicology, Pennsylvania State University Press, University Park, 1984.
5. Marasas W.F.O. Fumonisins: their implications for human and animal health. Nat. Toxins. 3:1995;193-198.
6. Shephard G.S., Thiel P.G., Stockenstrom S., Sydenham E.W. Worldwide survey of fumonisin contamination of maize and maize-based products. JAOAC. 79:1996;671-687.
7. Cawood M.E., Gelderblom W.C.A., Vleggaar R., Behrend Y., Thiel P.G., Marasas W.F.O. Isolation of the fumonisin mycotoxins: a quantitative approach. J. Agric. Food Chem. 39:1991;1958-1962.
8. Branham B.E., Plattner R.D. Isolation and characterisation of a new fumonisin from liquid cultures of Fusarium moniliforme. J. Nat. Prod. 56:1993;1630-1633.
9. Musser S.M., Gay M.L., Mazzola E.P., Plattner R.D. Identification of a new series of fumonisins containing 3-hydroxypyridine. J. Nat. Prod. 59:1996;970-972.
10. Rheeder J.P., Marasas W.F.O., Thiel P.G., Sydenham E.W., Shephard G.S., Van Schalkwyk D.J. Fusarium moniliforme and fumonisins in maize in relation to human eosophageal cancer in Transkei. Phytopathology. 82:1992;353-357.
11. Sydenham E.W., Thiel P.G., Marasas W.F.O., Shephard G.S., Van Schalwyk D.J., Koch K.R. Natural occurrence of some Fusarium mycotoxin maize from high and low eosophageal cancer prevalence areas of the Transkei, southern Africa. J. Agric. Food Chem. 38:1990;1900-1903.
12. 1 and other mycotoxins in moldy maize collected from the People's Republic of China in regions with high incidence of eosophageal cancer. Appl. Environ. Microbiol. 60:1994;847-852.
13. Yoshizawa T., Yamashita A., Luo Y. Fumonisin occurrence in maize from high- and low-risk areas for human esophageal cancer in China. Appl. Environ. Microbiol. 60:1994;1626-1629.
14. IARC, Monograph 56, Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins, International Agency for Research on Cancer, Lyon, France, 1993.
15. Chamberlain W.J., Bacon C.W., Norred W.P., Voss K.A. Levels of fumonisin B1 in maize naturally contaminated with aflatoxins. Food Chem. Toxicol. 31:1992;995-998.
16. Wang D.S., Liang Y.X., Chau N.T., Dien L.D., Tanaka T., Ueno Y. Natural co-occurrence of Fusarium toxins and aflatoxin B1 in maize feed in North Vietnam. Nat. Toxins. 3:1995;445-449.
17. Yamashita A., Aiura Y., Sanchez P.C., Dizon E.I., Arim R.H., Yoshizawa T. Fusarium mycotoxins (fumonisins, nivalenol, and zearalenone) and aflatoxins in maize from Southeast Asia. Biosci. Biotechnol. Biochem. 59:1995;1804-1807.
18. Yoshizawa T., Yamashita A., Chokethaworn N. Occurrence of fumonisins and aflatoxins in maize from Thailand. Food Addit. Contam. 13:1996;163-168.
19. Ueno Y., Iijima K., Wang S.D., Sugiura Y., Sekijima M., Tanaka T., Chen C., Yu S.Z. Fumonisins as a possible contributory risk factor for primary liver cancer: a 3-year study of maize harvested in Haimen, China, by HPLC and ELISA. Food Chem. Toxicol. 35:1997;1143-1150.
20. Ali N., Sardjono I., Yamashita A., Yoshizawa T. Natural co-occurrence of aflatoxins and Fusarium mycotoxins (fumonisins, deoxynivalenol, nivalenol and zearalenone) in maize from Indonesia. Food Addit. Contam. 15:1998;377-384.
21. Harvey R.B., Edrington T.S., Kubena L.F., Elissalde M.H., Rottinghaus G.E. Influence of aflatoxin and fumonisin B-1-containing culture material on growing barrows. Am. J. Vet. Res. 56:1995;1668-1672.
22. Kubena L.F., Harvey R.B., Buckley S.A., Edrington T.S., Rottinghaus G.E. Individual and combined effects of moniliformin present in Fusarium fujikuroi culture material and aflatoxin in broiler chicks. Poult. Sci. 76:1997;265-270.
23. Marasas W.F.O., Kellerman T.S., Gelderblom W.C.A., Coetzer J.A.W., Thiel P.G., Van der Lugt J.J. Leukoencephalomalacia in a horse induced by fumonisin B1, isolated from Fusarium moniliforme. J. Vet. Res. 55:1988;197-203.
24. Voss K.A., Norred W.P., Plattner R.D., Bacon C.W. Hepatoxicity and renal toxicity in rats of corn samples associated with field cases of equine leukonecephalomalacia. Food Chem. Toxicol. 27:1989;89-96.
25. Kellerman T.S., Marasas W.F.O., Thiel P.G., Gelderblom W.C.A., Coetzer J.A.W. Leukoencephalomalacia in two horses induced by oral dosing with fumonisin B1. J. Vet. Res. 57:1990;269-275.
26. Harrison L.R., Colvin B.M., Greene J.T., Newman L.E., Cole J.R. Jr. Pulmonary edema and hydrothorax in swine produced by fumonisin B1, a toxic metabolite of Fusarium moniliforme. J. Vet. Diagn. Invest. 2:1990;217-221.
27. Bucci T.J., Howard P.C. Effect of fumonisin mycotoxins in animals. J. Toxicol., Toxin. Rev. 15:1996;293-302.
28. Bucci T.J., Howard P.C., Tolleson W.H., Laborde J.B., Hansen D.K. Renal effects of fumonisin mycotoxins in animals. Toxicol. Pathol. 26:1998;160-164.
29. Penner J.D., Casteel S.W., Pittman L. Jr., Rottinghaus G.E., Wyatt R.D. Developmental toxicity of purified fumonisin B1 in pregnant Syrian hamsters. J. Appl. Toxicol. 18:1998;197-203.
30. Collins T.F., Sprando R.L., Black T.N., Shackelford M.E., Laborde J.B., Hansen D.K., Eppley R.M., Trucksess M.W., Howard P.C., Bryant M.A., Ruggles D.I., Olejnik N., Rorie J.I. Effects of fumonisin B1 in pregnant rats: Part 2. Food Chem. Toxicol. 36:1998;673-685.
31. Voss K.A., Plattner R.D., Riley R.T., Meredith F.I., Norred W.P. In vivo effects of fumonisin B1 producing and FB1 nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats. Mycopathologia. 141:1998;45-58.
32. Gelderblom W.C.A., Snyman S.D., Abel S., Lebepe-Mazur S., Smuts C.M., Van der Westhuizen L., Marasas W.F.O., Victor T.C., Knasmuller S., Huber W. Hepatotoxicity and carcinogenicity of the fumonisins in rats: a review regarding mechanistic implications for establishing risk in humans. Adv. Exp. Med. Biol. 392:1996;279-296.
33. Merrill A.H. Jr., Wang E., Vales T.R., Smith E.R., Schroeder J.J., Menaldino D.s., Alexander C., Crane H.M., Xia J., Liotta D.C., Meredith F.I., Riley R.T. Fumonisin toxicity and sphingolipid biosynthesis. Adv. Exp. Med. Biol. 392:1996;297-306.
34. Merrill A.H., Schmelz E.M., Wang E., Dillehay D.L., Rice L.G., Meridith F., Riley R.T. Importance of sphingolipids and inhibitors of sphingolipid metabolism as components of animal diets. J. Nutr. 127(S5):1997;S830-S833.
35. Wang E., Norred W.P., Bacon C.W., Riley R.T., Merrill A.H. Jr. Inhibition of sphingolipids biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. J. Biol. Chem. 266:1991;14486-14490.
36. Merrill A.H. Jr., Wang E., Gilchrist D.G., Riley R.T. Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Adv. Lipid Res. 26:1993;215-231.
37. Stevens V.L., Nimkar S., Jamison W.C., Liotta D.C., Merrill A.H. Jr. Characteristics of the growth inhibition and cytotoxicity of long chain (sphingoid bases for Chinese hamster ovary cells: evidence for an involvement in protein kinase C. Biochim. Biophys. Acta. 1051:1990;37-45.
38. Lee J.Y., Leonhardt L.G., Obeid L.M. Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. Biochem. J. 334:1998;457-461.
39. Tolleson W.H., Dooley K.L., Sheldon W.G., Thurman J.D., Bucci T.J., Howard P.C. The mycotoxin fumonisin induces apoptosis in cultured human cells and in the livers and kidneys of rats. Adv. Exp. Med. Biol. 392:1996;237-250.
40. Goel S., Schumacher J., Lenz S.D., Kemppainen B.W. Effects of Fusarium moniliforme isolates on tissue and serum sphingolipid concentrations in horses. Vet. Hum. Toxicol. 38:1996;265-270.
41. Wild C.P., Pisani P. Carcinogen DNA and protein adducts as biomarkers of human exposure in environmental cancer epidemiology. Cancer Detect. Prev. 22:1998;273-283.
42. Gelderblom W.C.A., Jaskiewicz K., Marasas W.F.O., Thiel P.G., Horak R.N., Vlegger R., Kriek N.P. Fumonisins - novel mycotoxins with cancer promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol. 54:1988;1806-1811.
43. W.C.A. Gelderblom, W.F.O. Marasas, R. Vleggaar, P.G. Thiel, M.E. Cawood, Fumonisins: isolation, chemical characterization and biological effects, Mycopathologia (1992) 117-116.
44. Gelderblom W.C.A., Semple E., Marasas W.F.O., Farber E. The cancer-initiating potential of the fumonisin B mycotoxins. Carcinogenesis. 13:1992;433-437.
45. Gelderblom W.C.A., Cawood M.E., Snyman S.D., Marasas W.F.O. Fumonisin B1 dosimetry in relation to cancer initiation in rat liver. Carcinogenesis. 15:1994;209-214.
46. 1, in rats. Carcinogenesis. 12:1991;1247-1251.
47. Gelderblom W.C.A., Snyman S.D. Mutagenicity of potentially carcinogenic mycotoxins produced by Fusarium moniliforme. Mycotoxin Res. 7:1991;46-52.
48. Norred W.P., Bacon C.W., Plattner R.D., Vesonder R.F. Differential cytotoxicity and mycotoxin content among isolates of Fusarium moniliforme. Mycopathologia. 115:1991;37-43.
49. Norred W.P., Wang E., Yoo H., Riley R.T., Merrill A.H. Jr. In vitro toxicology of fumonisins and the mechanistic implications. Mycopathologia. 117:1992;73-78.
50. Norred W.P., Plattner R.D., Vesonder R.F., Bacon C.W., Voss K.A. Effects of selected secondary metabolites of Fusarium moniliforme on unscheduled synthesis of DNA by primary rat hepatocytes. Food Chem. Toxicol. 30:1992;233-237.
51. Knasmuller S., Bresgen N., Kassi F., Mersch-Sundermann V., Gelderblom W., Zohrer E., Eckl P. Genotoxic effects of three Fusarium mycotoxins, fumonisin B1, moniliformin and vomitoxin in bacteria and in primary cultures of rat hepatocytes. Mutat. Res. 391:1997;39-48.
52. Schroeder J.J., Crane H.M., Xia J., Liotta D.C., Merrill A.H. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. J. Biol. Chem. 269:1994;3475-3481.
53. Schmelz E.M., Dombrink-Kurtzman M.A., Roberts P.C., Kozutsumi Y., Kawasaki T., Merrill A.H. Jr. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Toxicol. Appl. Pharmacol. 148:1998;252-260.
54. Ciacci-Zanella J.R., Merrill A.H. Jr., Wang E., Jones C. Characterization of cell-cycle arrest by fumonisin B1 in CV-1 cells. Food Chem. Toxicol. 36:1998;791-804.
55. Wild C.P., Castegnaro M., Ohgaki H., Garren L., Galendo D., Miller J.D. Absence of a synergistic effect between fumonisin B1 and N-nitrosomethylbenzylamine in the induction of oesophageal papillomas in the rat. Nat. Toxins. 5:1997;126-131.
56. Lim C.W., Parker H.M., Vesonder R.F., Haschek W.M. Intravenous fumonisin B1 induces cell proliferation and apoptosis in the rat. Nat. Toxins. 4:1996;34-41.
57. C.P. Wild, A.J. Hall, Epidemiology of mycotoxin-related disease, in: D.H. Howard, J.D. Miller (Eds.), The Mycota: VI. Human and Animal Relationships, Springer-Verlag, Berlin, 1996, pp. 213-227.
58. Yang C.S. Research on esophageal cancer in China: a review. Cancer Res. 40:1980;2633-2644.
59. Franceschi S., Bidoli E., Baron A.E., La Vecchia C. Maize and risk of cancers of the oral cavity, pharynx, and esophagus in northeastern Italy. JNCI. 82:1990;1407-1411.
60. C.P. Wild, A.W. Daudt, M. Castegnaro, The molecular epidemiology of mycotoxin-related disease, in: M. Miraglia, H. van Egmond, C. Brera, J. Gilbert (Eds.), Mycotoxins and Phycotoxins - Developments in Chemistry, Toxicology and Food Safety, 1998, pp. 213-221.
61. Van Rensburg S.J., Bradshaw E.S., Bradshaw D., Rose E.F. Oesophageal cancer in Zulu men, South Africa: a case-control study. Br. J. Cancer. 51:1985;399-405.
62. Jaskiewicz K., Marasas W.F., Lazarus C., Beyers A.D., Van Helden P.D. Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res. 8:1988;711-715.
63. Marasas W.F.O., Jaskiewicz K., Venter F.S., van Schalkwyk D.J. Fusarium moniliforme contamination of maize in oesophageal cancer areas in Transkei. S. Afr. Med. J. 74:1988;110-114.
64. Zhen Y., Yang S., Ding L., Han F., Yang W., Lui Q. The culture and isolation of fungi from the cereals in five high risk and three low incidence counties of oesophageal cancer in Henan province, China. Chin. J. Oncol. 6:1984;27-29.
65. Luo Y., Yoshizawa T., Katayama T. Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in maize and wheat from high- and low-risk areas for human esophageal cancer in China. Appl. Environ. Microbiol. 56:1990;3723-3726.
66. Thiel P.G., Marasas W.F., Sydenham E.W., Shephard G.S., Gelderblom W.C. The implications of naturally occurring levels of fumonisins in maize for human and animal health. Mycopathologia. 117:1992;3-9.
67. Montesano R., Hainaut P., Wild C.P. Hepatocellular carcinoma: from gene to public health. JNCI. 89:1997;1844-1851.
68. Prelusky D.B., Trenholm H.L., Rotter B.A., Miller J.D., Savard M.E., Yeung J.M., Scott P.M. Biological fate of fumonisin B1 in food-producing animals. Adv. Exp. Med. Biol. 392:1996;265-278.
69. Smith J.S., Thakur R.A. Occurrence of fate of fumonisins in beef. Adv. Exp. Med. Biol. 392:1996;39-55.
70. W.F.O. Marasas, Fumonisins: history, world-wide occurrence and impact, in: L.S. Jackson, J.W. DeVries, L.B. Bullerman (Eds.), Fumonisins in Food: Advances in Experimental Medicine and Biology, Plenum, 1996, pp. 1-18.
71. Patel S., Hazel C.M., Winterton A.G.M., Gleadle A.E. Surveillance of fumonisins in UK maize-based foods and other cereals. Food Addit. Contam. 14:1997;187-191.
72. Castelo M.M., Sumner S.S., Bullerman L.B. Occurrence of fumonisins in maize-based food products. J. Food Prot. 61:1998;704-707.
73. Ostry V., Ruprich J. Determination of the mycotoxin fumonisins in gluten-free diet (maize-based commodities) in the Czech Republic. Central Eur. J. Public Health. 6:1998;57-60.
74. de Nijs M., Sizoo E.A., Vermunt A.E., Notermans S.H., van Egmond H.P. The occurrence of fumonisin B1 in maize-containing foods in The Netherlands. Food Addit. Contam. 5:1998;385-388.
75. de Nijs M., van Egmond H.P., Nauta M., Rombouts F.M., Notermans S.H. Assessment of human exposure to fumonisin B1. J. Food Prot. 61:1998;879-884.
76. Dupuy J., Le Bars P., Boudra H., Le Bars J. Thermostability of fumonisin B1, a mycotoxin from Fusarium moniliforme, in maize. Appl. Environ. Microbiol. 59:1993;2864-2867.
77. Castelo M.M., Sumner S.S., Bullerman L.B. Stability of fumonisins in thermally processed maize products. J. Food Prot. 61:1998;1030-1033.
78. Brera C., Miraglia M., Colatosti M. Evaluation of the impact of mycotoxins on human health: sources of error. Microchemistry. 59:1998;45-49.
79. Sydenham E.W., Shephard G.S., Thiel P.G., Stockenstrom S., Snijman P.W., Van Schalkwyk D.J. Liquid chromatographic determination of fumonisins B1, B2, and B3 in maize: AOAC-IUPAC Collaborative Study. JAOAC Int. 79:1996;688-696.
80. Chu F.S. Immunochemical methods for fumonisins. Adv. Exp. Med. Biol. 392:1996;123-133.
81. A.J. Hall, C.P. Wild, Epidemiology of aflatoxin-related disease, in: D.A. Eaton, J.D. Groopman (Eds.), The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance, Academic Press, 1994, pp. 233-258.
82. Shephard G.S., Thiel P.G., Sydenham E.W., Savard M.E. Fate of a single dose of 14C-labelled fumonisin B1 in vervet monkeys. Nat. Toxins. 3:1995;145-150.
83. Shetty P.H., Bhat R.V. Sensitive method for the detection of fumonisin B1 in human urine. J. Chromatogr., B. 705:1998;171-173.
84. Shephard G.S., van der Westhuizen L., Thiel P.G., Gelderblom W.C., Marasas W.F., van Schalkwyk D.J. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material. Toxicon. 34:1996;527-534.
85. Riley R.T., Wang E., Schroeder J.J., Smith E.R., Plattner R.D., Abbas H., Yoo H.-S., Merrill A.H. Jr. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. Toxins. 4:1996;3-15.
86. Wang E., Ross P.F., Wilson T.M., Riley R.T., Merrill A.H. Jr. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. J. Nutr. 122:1992;1706-1716.
87. Merrill A.H. Jr., Wang E., Mullins R.E., Jamison W.C., Nimkar S., Liotta D.C. Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal. Biochem. 171:1988;373-381.
88. Riley R.T., Wang E., Merrill A.H. Jr. Liquid chromatographic determination of sphinganine and sphingosine: use of the free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins. JAOAC. 77:1994;533-540.
89. Castegnaro M., Garren L., Gaucher I., Wild C.P. Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues. Nat. Toxins. 4:1996;284-290.
90. Castegnaro M., Garren L., Galeno D., Gelderblom W.C.A., Chelule P., Dutton M.F., Wild C.P. Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure. J. Chromatogr., B. 720:1998;15-24.
91. Solfrizzo M., Advantaggiato G., Visconti A. Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure. J. Chromatogr., B. 692:1997;87-93.
92. Shephard G.S., van der Westhuizen L. Liquid chromatographic determination of the sphinganine/sphingosine ratio in serum. J. Chromatogr., B. 710:1998;219-222.
93. Norred W.P., Plattner R.D., Dombrink-Kurtzman M.A., Meredith F.I., Riley R.T. Rat liver slices: specificity of the response and structure-activity relationships. Toxicol. Appl. Pharmacol. 147:1997;63-70.
94. Riley R.T., An N.-H., Showker J.L., Yoo H.-S., Norred W.P., Chamberlain W.J., Wang E., Merrill A.H. Jr., Motelin G., Beasley V.R., Haschek W.M. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Toxicol. Appl. Pharmacol. 118:1993;105-112.
95. Sydenham E.W., Marasas W.F.O., Shephard G.S., Thiel P.G., Hirooka E.Y. Fumonisin concentrations in Brazilian feeds associated with field outbreaks of confirmed and suspected animal mycotoxicoses. J. Agri. Food Chem. 40:1992;994-997.
96. Ross R.K., Yuan J-M., Yu M.C., Wogan G.N., Qian G.-S., Tu J-T., Groopman J.D., Gao Y-T., Henderson B.E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 339:1992;943-946.
97. Shephard G.S., Sydenham E.W., Thiel P.G., Gelderblom W.C.A. Quantitative determination of fumonisin B1 and B2 by high performance liquid chromatography with fluorescence detection. J. Liq. Chromatogr. 13:1990;2077-2087.